- DARE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Daré Bioscience (DARE) 10-K/A2016 FY Annual report (amended)
Filed: 28 Apr 17, 12:00am
Exhibit 31.3
CERTIFICATIONS
I, Christopher D.T. Guiffre, certify that:
1. I have reviewed this Amendment No. 1 on Form 10-K/A to the Annual Report on Form 10-K for the year ended December 31, 2016 of Cerulean Pharma Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
|
|
|
|
Date: April 28, 2017 |
| By: |
| /s/ Christopher D.T. Guiffre |
|
|
|
| Christopher D.T. Guiffre |
|
|
|
| President and Chief Executive Officer |
|
|
|
| (Principal Executive Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.